Survival by race in men with chemotherapy-naive enzalutamide- or abiraterone-treated metastatic castration-resistant prostate cancer

BACKGROUND: Black men are more likely to be diagnosed with aggressive prostate cancer (PC) and die from PC than white men. However, black men with metastatic castration-resistant PC (mCRPC) had longer overall survival (OS) than white men when treated with certain agents in clinical trials. We analyz...

Descripción completa

Detalles Bibliográficos
Autores principales: George, Daniel J., Ramaswamy, Krishnan, Huang, Ahong, Russell, David, Mardekian, Jack, Schultz, Neil M., Janjan, Nora, Freedland, Stephen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385484/
https://www.ncbi.nlm.nih.gov/pubmed/34732856
http://dx.doi.org/10.1038/s41391-021-00463-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385484/
https://www.ncbi.nlm.nih.gov/pubmed/34732856
http://dx.doi.org/10.1038/s41391-021-00463-9

Ejemplares similares